Cannabis is also known as marijuana. It is a plant with psychoactive, medicinal, and fibrous properties. It is used for various purposes, such as recreational, medical, industrial, and religious uses. Cannabis testing includes a broad range of applications, from potency testing to pesticide screening. Cannabis testing is used to detect the plant’s active chemicals or breakdown products, most commonly in saliva or urine. In addition, cannabis testing may be used to screen for and confirm THC or THC metabolites that indicate marijuana or prescription cannabinoid use. Finally, cannabis may be included in a panel of drug tests used for medical screening and legal, forensic, or employment testing to determine if a person may have used marijuana.
The global cannabis testing market size was valued at USD 950.7 million in 2019 and projected to reach USD 1,801.52 million by 2027, growing at a CAGR of 11.30% during the forecast period, 2020-2027. The major factors are the legalization of cannabis for medical use across various countries. Additionally, the increasing number of cannabis testing laboratories and growing awareness regarding medical cannabis will spur the global cannabis testing industry in the future periods. Furthermore, the growing public-private funding for cannabis testing activities and rising investments for the cannabis industry are expected to witness remarkable growth of cannabis testing. Furthermore, the increasing R&D investment and growing demand for cannabis to treat chronic and deadly diseases like cancer are expected to propel the demand for cannabis testing over the coming years.
Moreover, the rigorous regulatory requirements implemented by authorities to ensure superior quality products are positively impacting the market for cannabis testing. Furthermore, the increasing cultivators of cannabis and the rise in testing laboratories fuel the demand for the cannabis testing market. Additionally, the rising prevalence of chronic diseases and increasing healthcare demands in the developing world is propelling the growth of the cannabis testing market across the globe.
The increasing demand for the legal legalization of medical cannabis will be the primary factor driving the cannabis testing market growth. Medical cannabis can be effective in various medical applications, such as controlling muscular spasms in multiple sclerosis patients, controlling nausea & vomiting caused by cancer chemotherapy, stimulating appetite, improving weight gain in people with cancer and AIDS, and reducing intraocular pressure patients with glaucoma. Due to their health benefits, various government organizations and private players recognize the importance of legalized medical cannabis. Countries like Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, and Uruguay allowed the medical use of whole-plant cannabis. According to a 2017 United Nations report, almost 70% of medical cannabis is exported from the United Kingdom, with much of the remaining amount coming from Canada and the Netherlands. The utilization of cannabis as medicine has resulted in a rise in clinical research, and the demand for the analytical testing of cannabis to ensure its safety before human consumption has increased in recent years. Moreover, some of the medical organizations have issued statements in support of allowing access to medical cannabis, including the American Nurses Association, American Public Health Association, American Medical Student Association, National Multiple Sclerosis Society, Epilepsy Foundation, and Leukemia & Lymphoma Society, which tends to drive the market growth. However, the high cost of setting up a cannabis testing facility can hamper the growth of the cannabis testing market.
The outbreak of COVID-19 has recently vigorously affected the life science and pharmaceutical industry of developed and developing countries globally. The growing nervousness regarding the shortage of essential medical life-saving devices and other necessary medical supplies to prevent the spread of this virus and provide optimum care to the infected also widens. Additionally, the various market players providing products and software to the cannabis testing industry witnessed a decline in sales due to disruption in the supply chain and trade restrictions and the shutdown of labs. However, the COVID-19 crisis also has a positive impact as some companies collaborate for research on cannabis extract to prevent infections.
Based on the product & software, the global cannabis testing market is segregated into analytical instruments, spectroscopy instruments, consumables, software, and services. The analytical instruments segment is estimated to witness the highest growth over the analysis timeframe due to the rise in adoption of effective testing techniques, technological advancements related to cannabis testing software & system, and rapid expansion in the customer base.
The service will grow significantly due to the rising demand for potency testing services that keep the consumer well informed about the quality.
Based on the testing procedures, the global cannabis testing market is categorized into potency testing, terpene profiling, residual solvent analysis, microbial analysis, pesticide screening, heavy metal testing, and other services. The potency testing segment is held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the rising use of cannabidiol for disease treatment. It is usually performed to determine the number of major cannabinoids.
The terpene profiling segment is poised to witness significant growth over the forecast period due to the ever-increasing state legalization of cannabis for medical use.
The global cannabis testing market is segmented into testing laboratories, research institutes, drug manufacturers & dispensaries, and cannabis cultivators/growers based on the end-user. The cannabis cultivators/growers segment will dominate the global cannabis testing market by 2027 due to strict rules and regulations by the government bodies on THC (tetrahydrocannabinol) content cannabis products. Besides, these growers need to sell different plants based on their CBD and THC content at different prices.
The drug manufacturers & dispensaries accounted for the largest share of the cannabis testing market in 2019 because of the increasing use of cannabis as a medicine and the rise in the number of cannabis-based clinical trials by large pharma players such as Pfizer and Solvay Pharmaceuticals.
The global cannabis testing market is segmented into Europe, North America, Asia Pacific, South America, and Middle East & Africa by geography. North America is to project considerable growth over 2020-2026. It is owing to the growing biopharmaceutical industry, the presence of leading industry players coupled with the legalization of cannabis for medical use, and the increasing number of cannabis testing laboratories in the region.
Europe will capture a prominent share of the cannabis testing market by 2027. Due to the rising investments by pharmaceutical and biotechnology companies, we are continually improving healthcare infrastructure in the region and increasing usage of the plant in drug development and research.
Companies such as Thermo Fisher Scientific, DigiPath Inc, Steep Hill Inc., SC Laboratories Inc, PharmLabs LLC, Shimadzu Scientific Instruments, Merck KGaA, Restek Corporation, PerkinElmer Inc, Waters Corporation, Hamilton Company, CanMedLabs, and Agilent Technologies Inc are the key players in the global cannabis testing market.
By Product & Software
By Testing Procedures
By End-User
By Region
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.